FDA OKs once-a-month osteoporosis pill

Osteoporosis sufferers soon will be able to take a monthly pill for their condition.

The Food and Drug Association has approved Boniva, the first monthly pill for brittle bones. Makers of the drug are Roche Holding AG and GlaxoSmithKline PLC, according to the Wall Street Journal.

Osteoporosis drugs previously had to be taken daily or weekly. They could be a hassle to take because patients had to stay standing for a period of time for the medication to take effect. Many patients discontinue treatment of osteoporosis drugs because of the way they must be taken.

While Boniva also requires patients to stand, it will be less burdensome because of the less-frequent dosage requirement. The companies estimate 44 million Americans over age 50 suffer from osteoporosis.

More in News

Government agency launches health IT webpage for long-term care providers

Government agency launches health IT webpage for long-term ...

The Office of the National Coordinator for Health Information Technology has unveiled a new webpage with information and resources for long-term and post-acute (LTPAC) providers.

FDA responds to provider pressure, backs off stricter control of fecal transplants ...

Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers, who pushed back after the FDA recently announced it would tighten regulations around the transplants.

Judge denies Omnicare's 'untimely' motion to disqualify whistleblower in nursing home kickbacks ...

Omnicare has failed to disqualify a whistleblower who alleges the long-term care pharmacy paid kickbacks to nursing homes, ruled a district court judge.